Microdose-based psychedelic drug therapies have several advantages , ranging from R&D and drug licensing all the way through to drug commercialization and market penetration. It all adds up to greater profit potential.
Microdose-based psychedelic drug therapies have several advantages , ranging from R&D and drug licensing all the way through to drug commercialization and market penetration. It all adds up to greater profit potential.
A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.
Oregon could become the first U.S. state to LEGALIZE the (medicinal) use of a psychedelic drug.
Psychedelic drug R&D is ramping up rapidly. The number of past and current clinical studies on these substances will surprise you.
Understanding the drug approval process that leads to drug patents and drug licensing is of critical importance for successful investing in psychedelics.
Mydecine Innovations Group has added one of the world's pre-eminent biotech scientists to its Scientific Advisory Board.
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Psychedelic drugs are a potential huge step forward in the treatment of an affliction that currently offers very poor treatment options.
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now